Dr. JoAnne Feeney

About Dr. JoAnne Feeney

Dr. JoAnne Feeney is a Portfolio Manager and a member of the investment committee with Advisors Capital Management, LLC (ACM). Prior to joining ACM, Dr. Feeney was senior equity analyst for more than 10 years at boutique sell-side firms including Punk, Ziegel & Co., FTN Equity Capital, Longbow Research, and ABR Investment Strategy where she focused on the valuation of semiconductor companies. Dr. Feeney also consulted for the Federal Reserve, The International Monetary Fund and The World Bank while an academic at The University at Albany, State University of New York, The Stern School of Business, New York University, and the University of Colorado at Boulder. Dr. Feeney has appeared often on Bloomberg, CNBC, and is frequently quoted by Barron’s and The Wall Street Journal. Dr. Feeney received her B.A. in economics from Union College, and her Ph.D. and M.A. in economics from the University of Rochester.

Although the news recently has been dominated by alarming headlines about inflation, the Delta variant, and high stock valuations, we have some positive developments to look forward to: second quarter earnings reports. This past quarter will likely deliver one of best year-over-year earnings growth rates in history—the other having occurred in the wake of the…

Last week’s decline through Wednesday and sudden rebound on Thursday and Friday may be a mere sample of what’s to come. Investors have become sensitive to high valuations and the presence of higher economic risks. But last week’s decline of 4% was a relatively minor drop, and the rebound left the S&P 500 down only…

Many investors benefitted last year from the sharp appreciation in stocks of popular work-from-home companies represented by the FANG stocks (FB, AMZN, NFLX, GOOG), while those looking for income were left behind. This year is off to a very different start as last week’s gyrations made clear, and rightly so. FANG+ stocks (ETF: FNGS )…

Last week was full of surprises, though by looking at the market’s performance you wouldn’t know it. Between the attack on the Capitol, the now 50-50 split in the Senate, and the first (net) loss in jobs since April, one might have expected a pullback in stocks. Yet last week, the major indices continued to…

The big news this morning is changing the investing landscape and adding to the positive market response to the election results. At 90% efficacy in the first release of a late-stage, large study trial, Pfizer’s vaccine candidate is giving investors renewed hope of controlling COVID and getting life back to normal. Not only are travel…

Federal Reserve Chairman Jay Powell announced a shift to an “inflation averaging” rule last week at the virtual Jackson Hole monetary policy conference and many investors are wondering whether this should alter portfolio strategy. The short answer is, for now, no. But what of concerns that the Federal Reserve is continuing to feed the market’s…

The market has been behaving like Dr. Jekyll and Mr. Hyde over the past month, bouncing between good and bad news. Which personality will arrive this week? The extent of uncertainty applies to this year’s earnings, but also 2021 and 2022. As we’ve noted before, we are in a strange situation where near-term risks are…

Investors saw it coming – as they often do. The reopening is underway. Restaurants are beginning to serve sit-down meals, beaches are open, hair is being cut, and nails polished. Workers are being called back to factories and offices, although many who can work remotely will continue to do so. The precipitous drop in GDP…

Earnings season got off to a rocky start, but that was to be expected. Comments from management teams regarding the future were laced with cautious sentiment. Even though most investors understand that companies will struggle to estimate this year’s sales and earnings, they are still hoping that companies have some visibility to the end of…

You may have forgotten, given more urgent concerns surrounding the coronavirus, but we are once again at the cusp of earnings season. Make no mistake, this will be ugly. First quarter results will begin to show the impact of the shutdowns, and second quarter guidance even more so. Earnings estimates from Wall Street analysts have…

© Advisors Capital Management, LLC